|
May 6
|
Best Momentum Stocks to Buy for May 6th
|
|
May 6
|
New Strong Buy Stocks for May 6th
|
|
May 6
|
CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement
|
|
May 5
|
MAIA Biotechnology Announces $1.08 Million Private Placement
|
|
Feb 24
|
MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million
|
|
Feb 18
|
MAIA Biotechnology Announces Private Placement of $2,715,000
|
|
Feb 22
|
MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
|
|
Dec 1
|
Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now
|
|
Nov 17
|
MAIA Biotechnology Announces Closing of $4 Million Registered Direct Offering
|
|
Nov 17
|
MAIA Biotechnology (NYSE: MAIA) Has Received FDA Orphan Drug Designation For THIO As A Treatment For Most Aggressive Brain Cancer
|
|
Nov 15
|
MAIA Biotechnology Announces $4 Million Registered Direct Offering
|
|
Oct 3
|
MAIA Biotechnology Announces FDA Clearance of IND Application for THIO, a First-in-Class Telomere Targeting Agent for the Treatment of Non-Small Cell Lung Cancer
|
|
Sep 28
|
MAIA Biotechnology Announces Share Repurchase Program
|
|
Aug 21
|
MAIA Biotechnology, Inc. (MAIA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
|